RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Experimental Autoimmune Encephalomyelitis
Accession: DOID:9002763
browse the term
Definition: An experimental animal model for central nervous system demyelinating disease. Inoculation with a white matter emulsion combined with FREUND'S ADJUVANT, myelin basic protein, or purified central myelin triggers a T cell-mediated immune response directed towards central myelin. The pathologic features are similar to MULTIPLE SCLEROSIS, including perivascular and periventricular foci of inflammation and demyelination. Subpial demyelination underlying meningeal infiltrations also occurs, which is also a feature of ENCEPHALOMYELITIS, ACUTE DISSEMINATED. Passive immunization with T-cells from an afflicted animal to a normal animal also induces this condition. (From Immunol Res 1998;17(1-2):217-27; Raine CS, Textbook of Neuropathology, 2nd ed, p604-5)
Synonyms: exact_synonym: Allergic Encephalomyelitis; EAE; Experimental Allergic Encephalomyelitides; Experimental Allergic Encephalomyelitis
primary_id: MESH:D004681
xref: EFO:0001066
G
ADAM17
ADAM metallopeptidase domain 17
ISO
RGD
PMID:15878627
RGD:1559178
NCBI chr2A:9,478,080...9,545,363
Ensembl chr2A:9,641,201...9,708,054
G
ADAM8
ADAM metallopeptidase domain 8
ISO
RGD
PMID:9670863
RGD:2325244
Ensembl chr10:134,172,724...134,186,227
G
AIF1
allograft inflammatory factor 1
ISO
protein:altered expression:spinal cord (rat)
RGD
PMID:19246105
RGD:2313022
NCBI chr 6:31,276,215...31,278,051
Ensembl chr 6:32,166,301...32,168,125
G
AKAP12
A-kinase anchoring protein 12
ISO
mRNA,protein:increased expression:spinal cord
RGD
PMID:20155814
RGD:14348972
NCBI chr 6:149,058,350...149,176,710
Ensembl chr 6:153,757,081...153,873,925
G
ALOX15
arachidonate 15-lipoxygenase
ISO
RGD
PMID:15328042
RGD:5509618
NCBI chr17:4,686,339...4,696,877
Ensembl chr17:4,677,125...4,687,669
G
AMIGO2
adhesion molecule with Ig like domain 2
severity
ISO
RGD
PMID:28119027
RGD:14392778
NCBI chr12:41,652,954...41,656,393
Ensembl chr12:42,525,858...42,527,426
G
ANXA1
annexin A1
ISO
protein:increased expression:brain, astrocyte, macrophage
RGD
PMID:9472682
RGD:2306942
NCBI chr 9:51,647,404...51,665,990
Ensembl chr 9:71,929,728...71,948,779
G
APOE
apolipoprotein E
ISO
RGD
PMID:28578430
RGD:13703134
NCBI chr19:41,853,669...41,857,252
Ensembl chr19:50,459,906...50,463,490
G
AQP4
aquaporin 4
severity disease_progression
ISO
RGD
PMID:19660138 PMID:21056916 PMID:21157915 PMID:23707078
RGD:5148015 RGD:5490116 RGD:5490117 RGD:8696030
NCBI chr18:20,108,607...20,122,381
Ensembl chr18:23,713,146...23,726,919
G
B2M
beta-2-microglobulin
ISO
RGD
PMID:15837577
RGD:6482690
NCBI chr15:23,668,108...23,674,791
Ensembl chr15:41,836,345...41,842,991
G
B4GALT6
beta-1,4-galactosyltransferase 6
ISO
mRNA:increased expression:astrocyte
RGD
PMID:25216636
RGD:14390079
NCBI chr18:24,840,106...24,906,309
Ensembl chr18:28,438,302...28,500,946
G
BDNF
brain derived neurotrophic factor
ISO
RGD
PMID:23212569
RGD:10059360
NCBI chr11:27,618,322...27,687,661
Ensembl chr11:27,520,312...27,589,239
G
C3
complement C3
ISO
protein:increased expression:cerebrospinal fluid
RGD
PMID:22320401
RGD:7175513
NCBI chr19:5,708,211...5,753,178
Ensembl chr19:6,629,287...6,674,699
G
C6
complement C6
severity
ISO
RGD
PMID:11970970
RGD:625607
NCBI chr 5:69,174,411...69,245,801
Ensembl chr 5:74,216,244...74,288,588
G
CACNA1B
calcium voltage-gated channel subunit alpha1 B
ISO
RGD
PMID:11353727
RGD:1580151
NCBI chr 9:108,989,621...109,256,841
G
CALCA
calcitonin related polypeptide alpha
no_association
ISO
RGD
PMID:19563774
RGD:5684360
NCBI chr11:15,055,897...15,061,539
Ensembl chr11:14,745,588...14,751,267
G
CASP3
caspase 3
ISO
protein:increased activity, increased expression:spinal cord
RGD
PMID:18521931
RGD:2311436
NCBI chr 4:176,793,190...176,815,023
Ensembl chr 4:189,018,422...189,040,185
G
CASP8
caspase 8
ISO
protein:increased activity, increased expression:spinal cord
RGD
PMID:18521931
RGD:2311436
NCBI chr2B:88,490,611...88,542,132
Ensembl chr2B:206,669,544...206,696,468
G
CASP9
caspase 9
ISO
protein:increased expression:spinal cord
RGD
PMID:18521931
RGD:2311436
NCBI chr 1:14,630,659...14,662,865
Ensembl chr 1:15,624,666...15,656,266
G
CAV3
caveolin 3
onset
ISO
Protein:increased expression:spinal cord, astrocyte
RGD
PMID:15925413
RGD:1582168
NCBI chr 3:8,684,829...8,697,731
Ensembl chr 3:8,928,069...8,940,942
G
CBLB
Cbl proto-oncogene B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20453840
NCBI chr 3:102,752,406...102,966,414
Ensembl chr 3:109,690,120...109,905,191
G
CCL1
C-C motif chemokine ligand 1
ISO
mRNA:decreased expression:lymph node
RGD
PMID:19865101
RGD:4145472
NCBI chr17:22,425,022...22,430,243
Ensembl chr17:22,719,425...22,722,341
G
CCL2
C-C motif chemokine ligand 2
ISO
mRNA:increased expression:spinal cord mRNA:decreased expression:lymph node mRNA:increased expression:optic chiasma (rat)
RGD
PMID:11241588 PMID:17666800 PMID:19865101
RGD:2307114 RGD:4145472 RGD:8548888
NCBI chr17:22,528,154...22,530,091
Ensembl chr17:22,820,890...22,823,384
G
CCL5
C-C motif chemokine ligand 5
ISO
mRNA:increased expression:spinal cord protein:increased expression:brain (mouse)
RGD
PMID:15833367 PMID:17666800
RGD:2307114 RGD:4890027
NCBI chr17:20,915,198...20,923,530
Ensembl chr17:21,210,798...21,219,172
G
CCR1
C-C motif chemokine receptor 1
ISO
RGD
PMID:14512166 PMID:14655765
RGD:5688165 RGD:5688167
NCBI chr 3:46,107,526...46,114,229
Ensembl chr 3:47,214,688...47,215,755
G
CCR2
C-C motif chemokine receptor 2
ISO
mRNA:increased expression:spinal cord
RGD
PMID:9655467
RGD:632391
NCBI chr 3:46,255,725...46,263,285
Ensembl chr 3:47,361,124...47,368,312
G
CCR3
C-C motif chemokine receptor 3
ISO
RGD
PMID:15034073
RGD:6893394
NCBI chr 3:46,147,928...46,172,947
Ensembl chr 3:47,253,878...47,278,630
G
CCR5
C-C motif chemokine receptor 5
ISO
mRNA:increased expression:spinal cord, macrophage, microglia (rat)
RGD
PMID:17484785
RGD:4890436
NCBI chr 3:46,273,096...46,278,471
Ensembl chr 3:47,380,321...47,381,379
G
CD28
CD28 molecule
ISO
RGD
PMID:16061730
RGD:2307203
NCBI chr2B:90,938,795...90,971,438
Ensembl chr2B:209,076,388...209,111,213
G
CD4
CD4 molecule
treatment
ISO
protein:decreased expression:T lymphocyte:
RGD
PMID:3097071 PMID:9138014
RGD:10058963 RGD:10058968
NCBI chr12:6,920,587...6,951,814
Ensembl chr12:6,834,011...6,864,204
G
CD80
CD80 molecule
ISO
RGD
PMID:9379015
RGD:6902906
NCBI chr 3:116,646,590...116,683,725
Ensembl chr 3:123,559,559...123,594,870
G
CD86
CD86 molecule
resistance disease_progression
ISO
protein:increased expression:spinal cord, blood vessel (rat)
RGD
PMID:10477557 PMID:20451260
RGD:4892207 RGD:4892227
NCBI chr 3:119,151,884...119,217,641
Ensembl chr 3:126,059,008...126,124,339
G
CIITA
class II major histocompatibility complex transactivator
ISO
RGD
PMID:15821736
RGD:1358146
NCBI chr16:9,819,440...9,885,379
Ensembl chr16:11,041,434...11,090,485
G
CNP
2',3'-cyclic nucleotide 3' phosphodiesterase
ISO
RGD
PMID:7541143 PMID:10650887 PMID:21107918
RGD:6483335 RGD:6483351 RGD:6483353
NCBI chr17:15,338,085...15,349,089
Ensembl chr17:15,560,056...15,568,916
G
COMT
catechol-O-methyltransferase
treatment
ISO
RGD
PMID:25242632
RGD:13450949
NCBI chr22:2,704,015...2,731,326
Ensembl chr22:18,375,434...18,402,387
G
CPB2
carboxypeptidase B2
ISO
RGD
PMID:22768796
RGD:7243111
NCBI chr13:26,926,788...26,979,767
G
CSPG4
chondroitin sulfate proteoglycan 4
ISO
protein:increased expression:spinal cord
RGD
PMID:20162860 PMID:21679768
RGD:5686852 RGD:5686863
NCBI chr15:54,583,010...54,621,240
Ensembl chr15:74,177,909...74,200,498
G
CTLA4
cytotoxic T-lymphocyte associated protein 4
ISO
RGD
PMID:9379015
RGD:6902906
NCBI chr2B:91,054,917...91,106,234
Ensembl chr2B:209,239,417...209,244,498
G
CTSC
cathepsin C
ISO
RGD
PMID:843913
RGD:1599653
NCBI chr11:83,299,827...83,345,383
Ensembl chr11:86,890,010...86,933,847
G
CTSS
cathepsin S
ISO
RGD
PMID:21439785
RGD:5686915
NCBI chr 1:126,084,249...126,118,221
Ensembl chr 1:129,733,996...129,768,318
G
CX3CL1
C-X3-C motif chemokine ligand 1
ISO
RGD
PMID:16053521
RGD:4891973
NCBI chr16:37,646,447...37,659,078
Ensembl chr16:56,779,065...56,791,760
G
CX3CR1
C-X3-C motif chemokine receptor 1
ISO
RGD
PMID:16053521 PMID:24706865
RGD:4891973 RGD:9491767
NCBI chr 3:39,158,346...39,176,604
Ensembl chr 3:39,440,955...39,457,219
G
CXCR2
C-X-C motif chemokine receptor 2
ISO
RGD
PMID:19616545
RGD:7257694
NCBI chr2B:105,387,198...105,400,533
Ensembl chr2B:223,997,066...223,998,148
G
CXCR3
C-X-C motif chemokine receptor 3
ISO
RGD
PMID:21038468
RGD:5135506
NCBI chr X:60,880,759...60,883,355
Ensembl chr X:70,933,160...70,935,756
G
DAB2
DAB adaptor protein 2
disease_progression
ISO
RGD
PMID:21890121
RGD:7243155
NCBI chr 5:70,951,198...71,004,836
Ensembl chr 5:76,022,143...76,041,443
G
DLK1
delta like non-canonical Notch ligand 1
ISO
RGD
PMID:24676147
RGD:150520045
NCBI chr14:81,348,380...81,356,607
Ensembl chr14:100,654,965...100,668,019
G
DLL1
delta like canonical Notch ligand 1
ISO
RGD
PMID:17947672
RGD:6482235
NCBI chr 6:168,440,192...168,449,071
Ensembl chr 6:173,534,292...173,544,759
G
DLL4
delta like canonical Notch ligand 4
ameliorates
ISO
RGD
PMID:21813770
RGD:155663662
NCBI chr15:19,871,584...19,881,817
Ensembl chr15:38,121,574...38,129,471
G
DUSP10
dual specificity phosphatase 10
ISO
RGD
PMID:15306813
RGD:7775013
NCBI chr 1:197,293,039...197,333,828
Ensembl chr 1:202,367,318...202,404,720
G
ENTPD1
ectonucleoside triphosphate diphosphohydrolase 1
disease_progression
ISO
RGD
PMID:19524108
RGD:9685491
NCBI chr10:92,365,267...92,511,852
Ensembl chr10:95,828,094...95,983,257
G
EPO
erythropoietin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:18382691
NCBI chr 7:92,747,671...92,750,886
Ensembl chr 7:106,148,062...106,150,974
G
ERN1
endoplasmic reticulum to nucleus signaling 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30661753
NCBI chr17:58,132,889...58,224,012
Ensembl chr17:63,226,949...63,317,825
G
ESR2
estrogen receptor 2
ISO
RGD
PMID:21182085 PMID:21565615
RGD:5508732 RGD:5508735
NCBI chr14:44,807,875...44,919,780
Ensembl chr14:63,064,402...63,131,303
G
FASLG
Fas ligand
treatment
ISO
RGD
PMID:10944459
RGD:12903984
NCBI chr 1:148,159,826...148,167,785
Ensembl chr 1:151,868,430...151,876,281
G
FGF2
fibroblast growth factor 2
ISO
mRNA:increased expression:spinal cord
RGD
PMID:8929896 PMID:9814819
RGD:8655647 RGD:9831448
NCBI chr 4:115,005,136...115,076,369
Ensembl chr 4:126,149,813...126,214,942
G
FLT1
fms related receptor tyrosine kinase 1
treatment
ISO
RGD
PMID:18721816
RGD:10402153
NCBI chr13:9,584,850...9,779,542
G
FOXO3
forkhead box O3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27742544
NCBI chr 6:106,360,519...106,485,676
Ensembl chr 6:110,406,266...110,516,272
G
GHRH
growth hormone releasing hormone
resistance
ISO
RGD
PMID:21846799
RGD:5687168
NCBI chr20:33,573,001...33,583,699
Ensembl chr20:34,687,587...34,693,240
G
GHRL
ghrelin and obestatin prepropeptide
treatment
ISO
RGD
PMID:19620309
RGD:12905041
NCBI chr 3:10,221,829...10,229,229
Ensembl chr 3:10,573,537...10,580,723
G
GJC2
gap junction protein gamma 2
ISO
protein:decreased expression:white matter of spinal cord, gap junction (mouse)
RGD
PMID:22461072
RGD:13208593
NCBI chr 1:203,551,556...203,561,702
G
GLI1
GLI family zinc finger 1
ISO
RGD
PMID:18991353
RGD:12801440
NCBI chr12:31,453,759...31,466,194
Ensembl chr12:31,710,057...31,722,473
G
GLUD1
glutamate dehydrogenase 1
ISO
mRNA, protein:decreased expression:spinal cord
RGD
PMID:9145307
RGD:6484657
NCBI chr10:83,498,338...83,540,730
G
GPX3
glutathione peroxidase 3
ISO
RGD
PMID:22320401
RGD:7175513
NCBI chr 5:146,447,939...146,456,476
G
HAVCR2
hepatitis A virus cellular receptor 2
ISO
mRNA:increased expression:spinal cord:
RGD
PMID:11823861 PMID:15913792
RGD:9686086 RGD:9686113
NCBI chr 5:152,486,125...152,514,004
Ensembl chr 5:159,108,915...159,131,007
G
HMGCR
3-hydroxy-3-methylglutaryl-CoA reductase
ISO
RGD
PMID:14691063 PMID:17085013
RGD:5508469 RGD:5508476
NCBI chr 5:39,936,630...39,961,519
Ensembl chr 5:40,548,919...40,573,785
G
IFNB1
interferon beta 1
exacerbates treatment ameliorates
ISO
RGD
PMID:8955226 PMID:9578846 PMID:18997868 PMID:19380780
RGD:401854237 RGD:401854246 RGD:401854247 RGD:5147399
NCBI chr 9:20,884,742...20,886,317
G
IFNG
interferon gamma
treatment disease_progression
ISO
RGD
PMID:15661899 PMID:22896638
RGD:10755692 RGD:7987912
NCBI chr12:65,663,764...65,668,732
Ensembl chr12:68,448,861...68,453,829
G
IGF1
insulin like growth factor 1
treatment
ISO
human protein in a rat model
RGD
PMID:7541143
RGD:6483353
NCBI chr12:99,986,887...100,066,773
Ensembl chr12:103,385,911...103,462,177
G
IL10
interleukin 10
treatment
ISO
RGD
PMID:23872438
RGD:7364993
NCBI chr 1:182,369,234...182,374,207
Ensembl chr 1:186,648,289...186,653,371
G
IL10RA
interleukin 10 receptor subunit alpha
ISO
RGD
PMID:12620647
RGD:2316323
NCBI chr11:112,820,445...112,835,603
Ensembl chr11:116,752,619...116,767,771
G
IL12A
interleukin 12A
ISO
RGD
PMID:12471147
RGD:724447
NCBI chr 3:157,011,675...157,019,897
Ensembl chr 3:165,061,505...165,068,666
G
IL12B
interleukin 12B
ISO
mRNA, protein:increased expression:lymph node
RGD
PMID:19233473
RGD:4831840
NCBI chr 5:154,706,467...154,722,231
Ensembl chr 5:161,325,303...161,335,381
G
IL13
interleukin 13
severity
ISO
RGD
PMID:7523520 PMID:18250480
RGD:5684366 RGD:5684367
NCBI chr 5:128,073,863...128,078,453
Ensembl chr 5:134,235,788...134,240,548
G
IL16
interleukin 16
ISO
RGD
PMID:17641011
RGD:5024940
NCBI chr15:60,181,827...60,299,406
Ensembl chr15:79,122,988...79,250,861
G
IL17A
interleukin 17A
treatment
ISO
mRNA, protein:increased expression:lymph node
RGD
PMID:16200068 PMID:16785554 PMID:19233473 PMID:20003332
RGD:4831840 RGD:4888522 RGD:4889113 RGD:9212317
NCBI chr 6:51,736,269...51,740,538
Ensembl chr 6:53,004,820...53,009,074
G
IL18
interleukin 18
ISO
mRNA:increased expression:spinal cord
RGD
PMID:9834127 PMID:9846824
RGD:4889542 RGD:4889543
NCBI chr11:107,024,376...107,045,194
Ensembl chr11:110,867,586...110,888,371
G
IL18R1
interleukin 18 receptor 1
ISO
mRNA:increased expression:lymph node
RGD
PMID:19269041
RGD:2311529
NCBI chr2A:99,419,686...99,462,650
G
IL1RN
interleukin 1 receptor antagonist
treatment
ISO
human protein in a rat model
RGD
PMID:7593560
RGD:8551836
NCBI chr2A:88,991,646...89,008,013
Ensembl chr2A:114,061,182...114,078,839
G
IL21
interleukin 21
ISO
RGD
PMID:18997868
RGD:5147399
NCBI chr 4:114,795,979...114,806,936
Ensembl chr 4:125,943,495...125,951,915
G
IL21R
interleukin 21 receptor
no_association disease_progression
ISO
RGD
PMID:18353312 PMID:18546146
RGD:6892939 RGD:6892940
Ensembl chr16:27,774,864...27,821,769
G
IL22
interleukin 22
ISO
RGD
PMID:19269041
RGD:2311529
NCBI chr12:65,757,069...65,762,418
Ensembl chr12:68,542,076...68,547,421
G
IL27
interleukin 27
ISO
protein:decreased expression:blood serum (mouse)
RGD
PMID:33403844
RGD:126790527
G
IL2RA
interleukin 2 receptor subunit alpha
ISO
RGD
PMID:19269041
RGD:2311529
NCBI chr10:6,053,549...6,103,863
G
IL32
interleukin 32
ameliorates
ISO
human gene in a mouse model
RGD
PMID:26564962
RGD:150340739
NCBI chr16:2,007,018...2,023,757
Ensembl chr16:3,179,637...3,203,929
G
IL4
interleukin 4
treatment
ISO
RGD
PMID:1383385 PMID:18239607
RGD:7829778 RGD:8142395
NCBI chr 5:128,091,342...128,099,886
Ensembl chr 5:134,253,039...134,261,581
G
IL6
interleukin 6
ISO
protein:increased expression:oligodendrocytes (rat)
RGD
PMID:9358769 PMID:23322593
RGD:12791289 RGD:2307412
NCBI chr 7:23,415,922...23,420,767
G
ITGA4
integrin subunit alpha 4
susceptibility treatment
ISO
rat bone marrow cells in a mouse model
RGD
PMID:12626659 PMID:18722022
RGD:9698418 RGD:9698436
NCBI chr2B:68,719,376...68,802,488
Ensembl chr2B:186,530,187...186,612,203
G
JAG1
jagged canonical Notch ligand 1
ISO
RGD
PMID:17947672
RGD:6482235
NCBI chr20:10,582,234...10,618,507
Ensembl chr20:10,582,094...10,618,383
G
JAK2
Janus kinase 2
ISO
RGD
PMID:22066025
RGD:6483041
NCBI chr 9:4,820,303...4,971,867
Ensembl chr 9:5,006,271...5,156,626
G
JAK3
Janus kinase 3
treatment
ISO
RGD
PMID:25012120
RGD:11533939
NCBI chr19:17,299,129...17,330,700
Ensembl chr19:18,283,560...18,300,964
G
KDR
kinase insert domain receptor
ISO
RGD
PMID:19233483
RGD:5684404
NCBI chr 4:68,813,894...68,861,018
Ensembl chr 4:75,377,375...75,427,109
G
KIT
KIT proto-oncogene, receptor tyrosine kinase
ISO
RGD
PMID:25972476
RGD:12910744
NCBI chr 4:69,199,543...69,282,323
Ensembl chr 4:75,761,946...75,844,473
G
LOC100972994
HLA class II histocompatibility antigen, DQ beta 1 chain
ISO
RGD
PMID:9834080 PMID:16194572 PMID:16723470
RGD:5147639 RGD:5147647 RGD:5147666
NCBI chr 6:32,237,395...32,244,201
Ensembl chr 6:33,353,599...33,360,272
G
LOC100979269
alpha-2-macroglobulin
treatment
ISO
RGD
PMID:1710603
RGD:10046021
NCBI chr12:9,154,457...9,202,833
Ensembl chr12:9,385,359...9,433,979
G
LOC100986475
metallothionein-2
ISO
mRNA:increased expression:brain (mouse)
RGD
PMID:19619133
RGD:6484112
NCBI chr16:36,894,853...36,895,826
Ensembl chr16:56,007,922...56,028,093
G
LOC100987081
HLA class II histocompatibility antigen, DR alpha chain
ISO
RGD
PMID:8676084
RGD:5490166
NCBI chr 6:32,105,421...32,110,579
Ensembl chr 6:32,982,228...32,987,417
G
LRP1
LDL receptor related protein 1
ISO
protein:increased expression:cerebellum, spinal cord
RGD
PMID:19299462
RGD:13800552
NCBI chr12:31,713,938...31,799,287
Ensembl chr12:31,966,149...32,051,979
G
LTA
lymphotoxin alpha
ISO
mRNA:increased expression:spinal cord mRNA:increased expression:brain
RGD
PMID:7593556 PMID:9184655
RGD:1625038 RGD:4143220
NCBI chr 6:31,233,411...31,235,409
Ensembl chr 6:32,123,353...32,125,375
G
MAPT
microtubule associated protein tau
treatment
ISO
RGD
PMID:15494405
RGD:1358431
NCBI chr17:11,373,220...11,506,669
Ensembl chr17:11,458,159...11,523,129
G
MBP
myelin basic protein
ISO
CTD Direct Evidence: marker/mechanism human sequence peptide in a rat model; associated with Herpesviridae infections
CTD RGD
PMID:11501064 PMID:12811845 PMID:15159442 PMID:16285900 PMID:17884951 PMID:24070732 More...
RGD:30296670 RGD:7349334
NCBI chr18:70,369,882...70,526,693
Ensembl chr18:73,629,522...73,755,351
G
MDK
midkine
ISO
RGD
PMID:9814819
RGD:9831448
NCBI chr11:46,339,365...46,342,388
Ensembl chr11:46,891,540...46,893,254
G
MMP2
matrix metallopeptidase 2
ISO
RGD
PMID:19922364
RGD:2325703
NCBI chr16:35,711,866...35,738,881
Ensembl chr16:54,812,694...54,844,279
G
MMP7
matrix metallopeptidase 7
ISO
RGD
PMID:9549496
RGD:8547909
NCBI chr11:97,467,037...97,477,305
Ensembl chr11:100,960,032...100,971,099
G
MMP9
matrix metallopeptidase 9
treatment
ISO
protein:increased expression:multiple tissues
RGD
PMID:9549496 PMID:20810258 PMID:22800566 PMID:24797785
RGD:13204762 RGD:13204801 RGD:8547909 RGD:8547936
NCBI chr20:42,346,305...42,354,018
Ensembl chr20:43,432,389...43,440,129
G
MOBP
myelin associated oligodendrocyte basic protein
ISO
RGD
PMID:10623862
RGD:27226694
NCBI chr 3:39,372,102...39,450,066
Ensembl chr 3:39,688,104...39,699,486
G
MOG
myelin oligodendrocyte glycoprotein
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:10384097 PMID:12799014 PMID:12904460 PMID:14624757 PMID:16931536 PMID:17654737 PMID:17728465 PMID:18566399 PMID:18667803 PMID:21068375 PMID:21317386 PMID:21341682 PMID:23360710 PMID:23547115 PMID:23639249 PMID:30661753 More...
RGD:9685372 RGD:9685373 RGD:9685375
NCBI chr 6:29,461,174...29,476,362
Ensembl chr 6:30,119,599...30,134,152
G
MT1X
metallothionein 1X
ISO
mRNA:increased expression:brain (mouse)
RGD
PMID:19619133
RGD:6484112
NCBI chr16:36,959,854...36,961,632
Ensembl chr16:56,092,218...56,093,976
G
MT3
metallothionein 3
ISO
mRNA:increased expression:brain (mouse)
RGD
PMID:19619133
RGD:6484112
NCBI chr16:36,875,919...36,877,558
Ensembl chr16:56,007,922...56,028,093
G
NCAM1
neural cell adhesion molecule 1
ISO
protein:decreased expression:hippocampus
RGD
PMID:17064783
RGD:40924670
NCBI chr11:107,845,507...108,160,441
Ensembl chr11:111,925,677...112,000,401
G
NEFL
neurofilament light chain
ISO
protein:increased expression:cerebrospinal fluid, spinal cord
RGD
PMID:16182933
RGD:2299007
NCBI chr 8:24,218,510...24,224,627
Ensembl chr 8:21,134,533...21,140,694
G
NFE2L2
NFE2 like bZIP transcription factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19910389
NCBI chr2B:64,509,446...64,544,600
Ensembl chr2B:182,214,116...182,248,085
G
NGF
nerve growth factor
ISO
protein, mRNA:increased expression:thalamus and cortex, CNS
RGD
PMID:8866783
RGD:5508386
NCBI chr 1:87,223,597...87,276,759
G
NGFR
nerve growth factor receptor
severity
ISO
mRNA:increased expression:central nervous system
RGD
PMID:8866783 PMID:16519950
RGD:5508312 RGD:5508386
NCBI chr17:8,089,600...8,109,361
Ensembl chr17:8,075,316...8,094,966
G
NOS2
nitric oxide synthase 2
ISO
RGD
PMID:21857957
RGD:5509069
NCBI chr17:28,984,295...29,021,516
Ensembl chr17:29,471,510...29,617,093
G
NR1H2
nuclear receptor subfamily 1 group H member 2
ISO
RGD
PMID:21266776
RGD:6480877
NCBI chr19:47,340,077...47,346,737
Ensembl chr19:56,243,124...56,250,024
G
NR3C1
nuclear receptor subfamily 3 group C member 1
ISO
RGD
PMID:17322387
RGD:4892331
NCBI chr 5:138,634,278...139,089,171
Ensembl chr 5:144,741,452...144,865,269
G
NTRK1
neurotrophic receptor tyrosine kinase 1
ISO
mRNA:increased expression:brain subventricular zone:
RGD
PMID:15589512
RGD:5684777
Ensembl chr 1:136,007,476...136,047,355
G
OLIG1
oligodendrocyte transcription factor 1
treatment
ISO
RGD
PMID:24941845
RGD:40902822
NCBI chr21:19,432,165...19,434,481
G
OLIG2
oligodendrocyte transcription factor 2
treatment
ISO
RGD
PMID:24941845 PMID:29682587
RGD:40902822 RGD:40902863
NCBI chr21:19,387,860...19,391,291
G
PDCD1
programmed cell death 1
susceptibility
ISO
RGD
PMID:24648472
RGD:40818258
NCBI chr12:130,849,353...130,858,776
G
PDGFB
platelet derived growth factor subunit B
treatment
ISO
RGD
PMID:16042218
RGD:11080975
NCBI chr22:20,127,223...20,148,407
Ensembl chr22:37,944,018...37,964,883
G
PDGFRA
platelet derived growth factor receptor alpha
treatment
ISO
RGD
PMID:16042218
RGD:11080975
NCBI chr 4:69,639,081...69,709,870
Ensembl chr 4:76,199,382...76,271,097
G
PDGFRB
platelet derived growth factor receptor beta
treatment
ISO
RGD
PMID:16042218
RGD:11080975
NCBI chr 5:145,538,330...145,580,312
Ensembl chr 5:151,543,891...151,585,530
G
PIK3CG
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma
ISO
RGD
PMID:20303183
RGD:6482686
NCBI chr 7:98,841,974...98,885,446
Ensembl chr 7:111,570,148...111,611,614
G
PLP1
proteolipid protein 1
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21068375 PMID:24941845
RGD:40902822
NCBI chr X:93,015,098...93,031,193
Ensembl chr X:103,353,184...103,412,513
G
PPARA
peroxisome proliferator activated receptor alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17261635
Ensembl chr22:45,218,364...45,302,970
G
PRF1
perforin 1
ISO
RGD
PMID:20708278
RGD:6482806
NCBI chr10:67,071,141...67,078,057
Ensembl chr10:69,597,574...69,603,070
G
PRKAA1
protein kinase AMP-activated catalytic subunit alpha 1
severity
ISO
RGD
PMID:19486896
RGD:6484540
NCBI chr 5:69,581,748...69,620,721
Ensembl chr 5:74,627,830...74,666,505
G
PTGS1
prostaglandin-endoperoxide synthase 1
ISO
protein:increased expression:cerebral cortex, cerebellum, spinal cord protein:increased expression:microglia, macrophage,
RGD
PMID:10229132 PMID:21667309
RGD:5688149 RGD:5688250
NCBI chr 9:93,495,365...93,517,557
Ensembl chr 9:121,837,095...121,859,283
G
PTGS2
prostaglandin-endoperoxide synthase 2
ISO
protein:increased expression:cerebral cortex, cerebellum, spinal cord protein:increased expression:endothelial cell
RGD
PMID:10229132 PMID:21667309
RGD:5688149 RGD:5688250
NCBI chr 1:162,205,534...162,214,130
Ensembl chr 1:166,355,845...166,364,519
G
PTN
pleiotrophin
ISO
mRNA:increased expression:spinal cord (rat)
RGD
PMID:9814819
RGD:9831448
NCBI chr 7:129,184,786...129,300,815
Ensembl chr 7:141,701,430...141,705,623
G
QKI
QKI, KH domain containing RNA binding
ISO
RGD
PMID:22740327
RGD:10045997
NCBI chr 6:161,361,413...161,523,414
G
RANGRF
RAN guanine nucleotide release factor
ISO
RGD
PMID:8557821
RGD:6771380
NCBI chr17:43,369,556...43,371,025
Ensembl chr17:48,101,744...48,103,394
G
RHOA
ras homolog family member A
severity
ISO
protein:increased expression:microglial cell, brain
RGD
PMID:17983427
RGD:2298887
NCBI chr 3:49,282,009...49,339,887
G
SERPINE1
serpin family E member 1
ISO
mRNA,protein:increased expression,increased activity:spinal cord, astrocyte:
RGD
PMID:11733372
RGD:13208549
NCBI chr 7:93,267,517...93,279,728
Ensembl chr 7:106,510,130...106,518,450
G
SHH
sonic hedgehog signaling molecule
ISO
RGD
PMID:15892298 PMID:18991353
RGD:12801423 RGD:12801440
NCBI chr 7:147,400,112...147,414,036
Ensembl chr 7:159,114,666...159,126,651
G
SIGMAR1
sigma non-opioid intracellular receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30661753
NCBI chr 9:34,471,362...34,474,459
G
SIRT1
sirtuin 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:23547115
NCBI chr10:64,368,878...64,401,684
Ensembl chr10:66,681,598...66,715,069
G
SLPI
secretory leukocyte peptidase inhibitor
treatment
ISO
RGD
PMID:22436018
RGD:9999395
NCBI chr20:41,583,429...41,585,773
Ensembl chr20:42,673,417...42,675,773
G
SNCB
synuclein beta
ISO
RGD
PMID:12496452
RGD:730073
NCBI chr 5:171,918,297...171,928,672
Ensembl chr 5:178,988,439...178,998,800
G
SRSF9
serine and arginine rich splicing factor 9
treatment
ISO
RGD
PMID:20616573
RGD:11040805
NCBI chr12:118,043,325...118,052,107
Ensembl chr12:121,417,557...121,425,708
G
STAT1
signal transducer and activator of transcription 1
ISO
RGD
PMID:22066025
RGD:6483041
NCBI chr2B:78,270,642...78,316,074
Ensembl chr2B:196,186,906...196,232,280
G
STAT3
signal transducer and activator of transcription 3
ISO
RGD
PMID:17878325 PMID:22066025
RGD:6483041 RGD:6892946
NCBI chr17:14,928,689...15,003,644
Ensembl chr17:15,152,358...15,227,067
G
STAT4
signal transducer and activator of transcription 4
ISO
RGD
PMID:11240014
RGD:7207888
NCBI chr2B:78,331,402...78,549,231
Ensembl chr2B:196,247,881...196,366,011
G
TGFB1
transforming growth factor beta 1
ISO
mRNA, protein:increased expression:central nervous system
RGD
PMID:17204936
RGD:2302088
NCBI chr19:38,324,009...38,347,003
Ensembl chr19:46,831,659...46,852,973
G
TGFB2
transforming growth factor beta 2
ISO
mRNA, protein:decreased expression:central nervous system
RGD
PMID:17204936
RGD:2302088
NCBI chr 1:193,907,398...194,005,800
Ensembl chr 1:198,758,751...198,859,041
G
TIMP3
TIMP metallopeptidase inhibitor 3
ISO
protein:increased expression:spinal cord
RGD
PMID:15878627
RGD:1559178
NCBI chr22:13,811,297...13,872,799
Ensembl chr22:31,662,562...31,723,964
G
TLR2
toll like receptor 2
ISO
protein:increased expression:spinal cord
RGD
PMID:18644848
RGD:2312575
NCBI chr 4:146,024,653...146,091,388
Ensembl chr 4:157,866,977...157,869,331
G
TLR4
toll like receptor 4
ISO
protein:increased expression:spinal cord
RGD
PMID:18644848
RGD:2312575
NCBI chr 9:88,827,495...88,840,458
Ensembl chr 9:117,180,550...117,190,711
G
TNF
tumor necrosis factor
treatment
ISO
RGD
PMID:11421579
RGD:12904661
NCBI chr 6:31,236,650...31,239,423
Ensembl chr 6:32,126,618...32,129,381
G
VCAM1
vascular cell adhesion molecule 1
ISO
RGD
PMID:12196270
RGD:1580348
NCBI chr 1:103,377,815...103,395,118
Ensembl chr 1:102,091,336...102,107,732
G
VDR
vitamin D receptor
treatment
ISO
RGD
PMID:21287548 PMID:21318047
RGD:13210791 RGD:8158064
NCBI chr12:40,828,413...40,891,700
Ensembl chr12:41,702,742...41,766,192
G
VEGFA
vascular endothelial growth factor A
ISO
mRNA,protein:decreased expression:spinal cord: mRNA:decreased expression:Cerebrospinal Fluid:
RGD
PMID:12387457 PMID:17083617
RGD:634258 RGD:7421596
NCBI chr 6:43,361,053...43,377,366
Ensembl chr 6:44,650,365...44,666,353
G
VIP
vasoactive intestinal peptide
ISO
RGD
PMID:20978211
RGD:5685386
NCBI chr 6:150,564,545...150,573,582
Ensembl chr 6:155,254,652...155,263,730
G
XBP1
X-box binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30661753
NCBI chr22:9,863,479...9,869,491
Ensembl chr22:27,567,041...27,571,943
G
MAG
myelin associated glycoprotein
ISO
protein:decreased expression:optic nerve
RGD
PMID:9820787
RGD:9685300
NCBI chr19:32,238,457...32,260,497
Ensembl chr19:40,975,763...40,997,401
G
ZC3H12A
zinc finger CCCH-type containing 12A
disease_progression
ISO
RGD
PMID:26320658
RGD:11534569
NCBI chr 1:36,743,341...36,753,261
Ensembl chr 1:38,093,917...38,103,556
G
CCL2
C-C motif chemokine ligand 2
ISO
mRNA:increased expression:spinal cord (rat)
RGD
PMID:12098510
RGD:8655962
NCBI chr17:22,528,154...22,530,091
Ensembl chr17:22,820,890...22,823,384
G
NEFH
neurofilament heavy chain
ISO
protein:decreased expression:spinal cord:
RGD
PMID:12742652
RGD:27226817
NCBI chr22:10,525,738...10,536,788
G
PLP1
proteolipid protein 1
ISO
human sequence peptide in a mouse model; associated with Herpesviridae infections
RGD
PMID:12811845
RGD:30296670
NCBI chr X:93,015,098...93,031,193
Ensembl chr X:103,353,184...103,412,513
G
SERPINE1
serpin family E member 1
ISO
RGD
PMID:17983428
RGD:13208507
NCBI chr 7:93,267,517...93,279,728
Ensembl chr 7:106,510,130...106,518,450
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all